Abstract
To elucidate the protective mechanism of lobetyolin on oxygen–glucose deprivation/reperfusion (OGD/R)-induced damage in BV2 microglial cells. The OGD/R model was established using a chemical modeling method to simulate in vivo brain ischemia in lobetyolin-pretreated BV2 cells. The optimum lobetyolin dosage, chemical concentration, and OGD/R modeling duration were screened. The changes in cell morphology were observed, and the levels of immune response-related factors, including tumor necrosis factor-α (TNF-α), interleukin-6, inducible nitric oxide synthase (iNOS), and cluster of differentiation (CD)206, were detected using the enzyme-linked immunosorbent assay. The expression of chemokine-like-factor-1 (CKLF1), hypoxia-inducible factor (HIF)-1α, TNF-α, and CD206, was detected using western blotting. The gene expression of M1 and M2 BV2 phenotype markers was assessed using quantitative polymerase chain reaction (qPCR). The localization of M1 and M2 BV2 markers was detected using immunofluorescence analysis. The results showed that lobetyolin could protect BV2 cells from OGD/R-induced damage. After OGD/R, CKLF1/C–C chemokine receptor type 4 (CCR4) levels increased in BV2 cells, whereas the CKLF1/CCR4 level was decreased due to lobetyolin pretreatment. Additionally, BV2 cells injured with OGD/R tended to be M1 type, but lobetyolin treatment shifted the phenotype of BV2 cells from M1 type to M2 type. Lobetyolin decreased the expression of TNF-α and HIF-1α but increased the expression of transforming growth factor-β (TGF-β) in BV2 cells, indicating a dose–effect relationship. The qPCR results showed that lobetyolin decreased the expression of CD16, CD32, and iNOS at the gene level and increased the expression of C–C-chemokine ligand-22 and TGF-β. The immunofluorescence analysis showed that lobetyolin decreased CD16/CD32 levels and increased CD206 levels. Lobetyolin can protect BV2 cells from OGD/R-induced damage by regulating the phenotypic polarization of BV2 and decreasing inflammatory responses. Additionally, CKLF1/CCR4 may participate in regulating lobetyolin-induced polarization of BV2 cells via the HIF-1α pathway.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- OGD/R:
-
Oxygen glucose deprivation/re-oxygenaion
- CKLFI:
-
Chemokine-like-factor 1
- CCR4:
-
C-C chemokine receptor type 4
- HIF-1α:
-
Hypoxiainduciblefactor-1α
- TGF-β:
-
Transforming growth factor beta
- TNF- α:
-
Tumor necrosis factor- α
- CD-16:
-
Cluster of differentiation-16
- CD32:
-
Cluster of differentiation-32
- CD206:
-
Cluster of differentiation-206
- CCL-22:
-
CC-chemokine ligand-22
- IL-1β:
-
Interleukin-1β
- IL-2:
-
Interleukin-2
- IL-4:
-
Interleukin-4
- IL-6:
-
Interleukin-6
- IL-10:
-
Interleukin-10
- IL-12:
-
Interleukin-12
- IL-23:
-
Interleukin-23
- IL-1Ra:
-
Interleukin-1Ra
- iNOS:
-
Inducible nitric oxide synthase
- VEGF-A:
-
Vascular endothelial growth factor-A
- CCK-8:
-
Cell Counting Kit-8
- ELISA:
-
Enzyme-Linked immunosorbent assay
- qPCR:
-
Quantitative PCR Detecting System
- WB:
-
Western blot
- Eda:
-
Edaravonc
- CCI:
-
Chronic Cerebral ischemia
References:
Abbas AK, Trotta E, Simeonov RD et al (2018) Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol 3:eaat1482. https://doi.org/10.1126/sciimmunol.aat1482
Bailly C (2021) Anticancer Properties of Lobetyolin, an Essential Component of Radix Codonopsis (Dangshen). Nat Prod Bioprospect 11:143–153. https://doi.org/10.1007/s13659-020-00283-9
Brás JP, Bravo J, Freitas J et al (2020) TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity. Cell Death Dis 11:415. https://doi.org/10.1038/s41419-020-2626-6
Cai X, Deng J, Ming Q et al (2020) Chemokine-like factor 1: A promising therapeutic target in human diseases. Exp Biol Med (maywood) 245:1518–1528. https://doi.org/10.1177/1535370220945225
Castro LVG, Gonçalves-de-Albuquerque CF, Silva AR (2022) Polarization of Microglia and Its Therapeutic Potential in Sepsis. Int J Mol Sci 23:4925. https://doi.org/10.3390/ijms23094925
Chen Y, Colonna M (2021) Microglia in Alzheimer’s disease at single-cell level. Are there common patterns in humans and mice? J Exp Med 218:e20202717. https://doi.org/10.1084/jem.20202717
Chen C, Ai Q, Chu S et al (2019) IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization. Int Immunopharmacol 70:69–79. https://doi.org/10.1016/j.intimp.2019.02.012
Cowman SJ, Koh MY (2022) Revisiting the HIF switch in the tumor and its immune microenvironment. Trends Cancer 8:28–42. https://doi.org/10.1016/j.trecan.2021.10.004
De Picker LJ, Victoriano GM, Richards R et al (2021) Immune environment of the brain in schizophrenia and during the psychotic episode: A human post-mortem study. Brain Behav Immun 97:319–327. https://doi.org/10.1016/j.bbi.2021.07.017
Du X, Xu Y, Chen S, Fang M (2020) Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway. Neural Plast 2020:8825954. https://doi.org/10.1155/2020/8825954
Gaviglio EA, Peralta Ramos JM, Arroyo DS et al (2022) Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-γ-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain. Int Immunopharmacol 105:108546. https://doi.org/10.1016/j.intimp.2022.108546
Ge Y-Y, Duan H-J, Deng X-L (2021) Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome. Chin Med J (engl) 134:1661–1668. https://doi.org/10.1097/CM9.0000000000001449
He Q, Ma Y, Liu J et al (2021) Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke. Front Immunol 12:801985. https://doi.org/10.3389/fimmu.2021.801985
Hu Z, Deng N, Liu K et al (2020) CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia. Cell Rep 31:107657. https://doi.org/10.1016/j.celrep.2020.107657
Hughes CE, Nibbs RJB (2018) A guide to chemokines and their receptors. FEBS J 285:2944–2971. https://doi.org/10.1111/febs.14466
Infantino V, Santarsiero A, Convertini P et al (2021) Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci 22:5703. https://doi.org/10.3390/ijms22115703
Jia X, Gao Z, Hu H (2021) Microglia in depression: current perspectives. Sci China Life Sci 64:911–925. https://doi.org/10.1007/s11427-020-1815-6
Jiang M, Wang H, Jin M et al (2018) Exosomes from MiR-30d-5p-ADSCs Reverse Acute Ischemic Stroke-Induced, Autophagy-Mediated Brain Injury by Promoting M2 Microglial/Macrophage Polarization. Cell Physiol Biochem 47:864–878. https://doi.org/10.1159/000490078
Jiang C-T, Wu W-F, Deng Y-H, Ge J-W (2020) Modulators of microglia activation and polarization in ischemic stroke (Review). Mol Med Rep 21:2006–2018. https://doi.org/10.3892/mmr.2020.11003
Kang N, Shi Y, Song J et al (2022) Resveratrol reduces inflammatory response and detrimental effects in chronic cerebral hypoperfusion by down-regulating stimulator of interferon genes/TANK-binding kinase 1/interferon regulatory factor 3 signaling. Front Aging Neurosci 14:868484. https://doi.org/10.3389/fnagi.2022.868484
Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469–1480. https://doi.org/10.1124/mol.106.027029
Kolios AGA, Tsokos GC, Klatzmann D (2021) Interleukin-2 and regulatory T cells in rheumatic diseases. Nat Rev Rheumatol 17:749–766. https://doi.org/10.1038/s41584-021-00707-x
Li H-S, Zhou Y-N, Li L et al (2019) HIF-1α protects against oxidative stress by directly targeting mitochondria. Redox Biol 25:101109. https://doi.org/10.1016/j.redox.2019.101109
Li Y, Yu H, Feng J (2023) Role of chemokine-like factor 1 as an inflammatory marker in diseases. Front Immunol 14:1085154. https://doi.org/10.3389/fimmu.2023.1085154
Liu S, Gao Y, Yu X et al (2016) Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion. Int J Mol Sci 17:1770. https://doi.org/10.3390/ijms17101770
Liu D-D, Song X-Y, Yang P-F et al (2018) Progress in pharmacological research of chemokine like factor 1 (CKLF1). Cytokine 102:41–50. https://doi.org/10.1016/j.cyto.2017.12.002
Lücht J, Rolfs N, Wowro SJ et al (2021) Cooling and Sterile Inflammation in an Oxygen-Glucose-Deprivation/Reperfusion Injury Model in BV-2 Microglia. Mediators Inflamm 2021:8906561. https://doi.org/10.1155/2021/8906561
Luo H, Guo H, Zhou Y et al (2023) Neutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe. Curr Neuropharmacol 21:2079–2096. https://doi.org/10.2174/1570159X21666230308090351
Masoud GN, Li W (2015) HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B 5:378–389. https://doi.org/10.1016/j.apsb.2015.05.007
Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367–402. https://doi.org/10.1146/annurev-immunol-032713-120240
Niu J-Z, Zhang Y-B, Li M-Y, Liu L-L (2011) Lessening effect of hypoxia-preconditioned rat cerebrospinal fluid on oxygen-glucose deprivation-induced injury of cultured hippocampal neurons in neonate rats and possible mechanism. Sheng Li Xue Bao 63:491–497
Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173:649–665. https://doi.org/10.1111/bph.13139
Peng Y, Chu S, Yang Y et al (2021) Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders. Front Pharmacol 12:671734. https://doi.org/10.3389/fphar.2021.671734
Plastino F, Pesce NA, André H (2021) MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases. Acta Ophthalmol 99:e1255–e1262. https://doi.org/10.1111/aos.14845
Plastira I, Bernhart E, Goeritzer M et al (2016) 1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype. J Neuroinflammation 13:205. https://doi.org/10.1186/s12974-016-0701-9
Prinz M, Jung S, Priller J (2019) Microglia Biology: One Century of Evolving Concepts. Cell 179:292–311. https://doi.org/10.1016/j.cell.2019.08.053
Qiu L, Ng G, Tan EK et al (2016) Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice. Sci Rep 6:23964. https://doi.org/10.1038/srep23964
Raffaele S, Lombardi M, Verderio C, Fumagalli M (2020) TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions. Cells 9:2145. https://doi.org/10.3390/cells9102145
Shemer A, Scheyltjens I, Frumer GR et al (2020) Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge. Immunity 53:1033-1049.e7. https://doi.org/10.1016/j.immuni.2020.09.018
Suzumura A, Ito A, Mizuno T (2003) Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development. Mult Scler 9:574–578. https://doi.org/10.1191/1352458503ms970oa
Thangwong P, Jearjaroen P, Govitrapong P et al (2022) Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats. Biochem Pharmacol 198:114980. https://doi.org/10.1016/j.bcp.2022.114980
Uemura A, Fruttiger M, D’Amore PA et al (2021) VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 84:100954. https://doi.org/10.1016/j.preteyeres.2021.100954
Wang H, Peng G, Wang B et al (2020) IL-1R-/- alleviates cognitive deficits through microglial M2 polarization in AD mice. Brain Res Bull 157:10–17. https://doi.org/10.1016/j.brainresbull.2019.11.020
Wang F, Ding P, Liang X et al (2022) Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level. Nat Commun 13:3620. https://doi.org/10.1038/s41467-022-31388-z
West PK, McCorkindale AN, Guennewig B et al (2022) The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes. J Neuroinflammation 19:96. https://doi.org/10.1186/s12974-022-02441-x
Willis EF, MacDonald KPA, Nguyen QH et al (2020) Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. Cell 180:833-846.e16. https://doi.org/10.1016/j.cell.2020.02.013
Wu X, Saito T, Saido TC et al (2021) Microglia and CD206+ border-associated mouse macrophages maintain their embryonic origin during Alzheimer’s disease. Elife 10:e71879. https://doi.org/10.7554/eLife.71879
Xiao W, Su J, Gao X et al (2022) The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids. Microbiome 10:62. https://doi.org/10.1186/s40168-022-01255-6
Yang L, Liu C, Li W et al (2021) Depression-like behavior associated with E/I imbalance of mPFC and amygdala without TRPC channels in mice of knockout IL-10 from microglia. Brain Behav Immun 97:68–78. https://doi.org/10.1016/j.bbi.2021.06.015
Ye Y, Jin T, Zhang X et al (2019) Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway. Front Cell Neurosci 13:553. https://doi.org/10.3389/fncel.2019.00553
Zhang D, Lv F-L, Wang G-H (2018) Effects of HIF-1α on diabetic retinopathy angiogenesis and VEGF expression. Eur Rev Med Pharmacol Sci 22:5071–5076. https://doi.org/10.26355/eurrev_201808_15699
Zhang J, Liu Y, Zheng Y et al (2020) TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus. J Neuroinflammation 17:2. https://doi.org/10.1186/s12974-019-1688-9
Zhang M-M, Guo M-X, Zhang Q-P et al (2022) IL-1R/C3aR signaling regulates synaptic pruning in the prefrontal cortex of depression. Cell Biosci 12:90. https://doi.org/10.1186/s13578-022-00832-4
Zhou X, Zhang Y-N, Li F-F et al (2022) Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke. Acta Pharmacol Sin 43:1217–1230. https://doi.org/10.1038/s41401-021-00746-w
Acknowledgements
This research was supported by grants from National Natural Science Foundation of China (U21A20410), (81874420), (82274388), (82004236); Key Program of Shanxi Province (International Science and Technology Cooperation) Major regional innovation cooperation project (201803D421006) , (201903D421018) .
Funding
This research was supported by grants from National Natural Science Foundation of China (U21A20410), (81874420), (82274388), (82004236); Key Program of Shanxi Province (International Science and Technology Cooperation) Major regional innovation cooperation project (201803D421006),(201903D421018).
Author information
Authors and Affiliations
Contributions
Junlong Zhang, Wenbin He, and Jie Wang developed the study conception and design. Wenyi Wei, Xin Liu and Jie Wang performed the experiment. Shifeng Chu, Jing Yang and Qinqing Li carried out the data analysis. Junlong Zhang, Wenbin He, Pulin Liu and Jie Wang developed the statistical analysis. The first draft of the manuscript was written by Junlong Zhang, Wenbin He, and Jie Wang. Xin Liu and Shifeng Chu conducted the written review. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no competing.
interests.
Ethics approval
All studies were approved by the Care Committee of Shanxi University of Chinese Medicine (Jinzhong, China).
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, J., Liu, X., Wei, W. et al. Regulation of oxygen–glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin. Metab Brain Dis 38, 2627–2644 (2023). https://doi.org/10.1007/s11011-023-01292-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01292-6